Is Bluebird Bio Stock a Buy?
This small biotech is struggling to fly -- and investors should probably steer clear.
Better Buy: Bluebird Bio Vs. Novavax
Who wins this face-to-face between two beaten-down biotechs?
Is This Beaten-Down Stock a Good Acquisition Target?
This company has proven its innovative abilities, but that's not enough to outperform the market.
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.
Why Bluebird Bio Stock Flew Higher Than the Market Today
The company was thrown a financial lifeline.